As a result, current guidelines for the diagnosis and treatment of patients with advanced non-small cell lung cancer (NSCLC) recommend that EGFR genotyping be performed in tumors with non-squamous histologies6,7. Here, EGFR is linked to non-small cell lung carcinoma.